Phase 3Not yet recruitingAge-related condition
Bone Marrow Aspirate Concentrate (BMAC) Treatment for Knee Osteoarthritis (ACCELERATE3)
Bone Marrow Aspirate ConCentrate for the Treatment of knEe Osteoarthritis: A Phase III, muLti-centER, Pan-cAnadian, prospecTivE Trial
- Sponsor
- CELL Technologies Inc. (Industry)
- Enrollment
- 374 planned
- Conditions
- Knee Osteoarthritis; Musculoskeletal Diseases
- Interventions
- Autologous Bone Marrow Aspirate Concentrate
- Ages
- adults, older adults
- Registry
- NCT06216028
Full record on ClinicalTrials.gov
From the registry
The purpose of the ACCELERATE3 trial is to assess the efficacy of a single intra-articular (IA) injection of autologous BMAC, in one or both knees, compared to a single IA injection of Standard of Care (SOC) in patients with mild to severe knee OA.
Primary outcomes
- WOMAC® Pain Subscore
History
Study completion expected
Primary completion
Started
Last registry update
Registered